• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
UCM 0.00% 3.2¢

USCOM LIMITED - Announcements

Uscom Limited is a medical technology company. It specializes in the development and... Uscom Limited is a medical technology company. It specializes in the development and marketing of non-invasive cardiovascular and pulmonary medical devices. It has three suites of devices in the field of cardiac, vascular, and pulmonary monitoring: the USCOM 1A advanced haemodynamic monitor, Uscom BP+ central blood pressure monitor, and the Uscom SpiroSonic digital ultrasonic spirometers. The USCOM 1A is a non-invasive advanced haemodynamic monitor that measures cardiovascular function, detects irregularities, and is used to guide treatment. The USCOM 1A device has applications in emergency, intensive care medicine and anesthesia. The Uscom BP+ is a supra-systolic oscillometric central blood pressure monitor which measures blood pressure and blood pressure waveforms in the heart, as well as in the arm, information only previously available using invasive cardiac catheterization. Its VENTITEST digital ultrasonic ventilator testing solution is a new system for testing ventilators.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk

Filters [Clear]
  • Price Sensitive: Yes
UCM Uscom Granted Type II Medical Device Sales Cert in ChinaPRICE SENSITIVE25/03/19
UCM Half Year AccountsPRICE SENSITIVE28/02/19
UCM Uscom Signs SpiroSonic Deal with US eHealth Leader - KoneksaPRICE SENSITIVE07/02/19
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
UCM Uscom Ltd 2018 AGM PresentationPRICE SENSITIVE28/11/18
UCM Uscom China IP GrantedPRICE SENSITIVE19/11/18
UCM Uscom China RegisteredPRICE SENSITIVE12/11/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/10/18
UCM Preliminary Final ReportPRICE SENSITIVE22/08/18
UCM Uscom releases new hypertension productPRICE SENSITIVE02/08/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
UCM New Uscom Measure of Heart FunctionPRICE SENSITIVE21/06/18 download Created with Sketch. 475.8KB
UCM New US IP for Uscom SpiroSonic DevicesPRICE SENSITIVE24/05/18 download Created with Sketch. 480.54KB
UCM Appendix 4C - quarterlyPRICE SENSITIVE23/04/18
UCM BP Plus for US eHealth studyPRICE SENSITIVE06/03/18
UCM Half Yearly Report and AccountsPRICE SENSITIVE14/02/18
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/01/18
UCM Share placementPRICE SENSITIVE19/12/17
UCM International Value Investor Takes Strategic Stake in UscomPRICE SENSITIVE18/12/17
UCM Uscom Receives $492K R&D Cash RefundPRICE SENSITIVE15/12/17
UCM Trading HaltPRICE SENSITIVE15/12/17
UCM New Hypertension Study Recommends Uscom BP Plus MeasuresPRICE SENSITIVE21/11/17
UCM Uscom receives GSA listing to sell to US GovernmentPRICE SENSITIVE13/11/17
UCM Uscom BP plus Central Blood Pressure Monitor ReleasedPRICE SENSITIVE30/10/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/10/17
UCM BP Plus and Mount Everest Hypertension StudyPRICE SENSITIVE16/10/17
UCM USCOM cost effective replacement for ICU UltrasoundPRICE SENSITIVE09/10/17
UCM Preliminary Final ReportPRICE SENSITIVE22/08/17
UCM Annual Report to shareholdersPRICE SENSITIVE21/08/17
UCM New USCOM 1A digital connectivity feature releasedPRICE SENSITIVE09/08/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE25/07/17
UCM Uscom BPplus Distributor for SE AsiaPRICE SENSITIVE17/07/17
UCM TGA for Uscom SpiroSonic Digital SpirometersPRICE SENSITIVE13/07/17
UCM Euro Funding for Uscom Pulmonary ResearchPRICE SENSITIVE11/07/17
UCM Uscom SpiroSonic Devices for Spanish Health ProjectPRICE SENSITIVE01/06/17
UCM Uscom SpiroSonic Devices for French Lung Transplant StudyPRICE SENSITIVE24/05/17
UCM Uscom boosts global sales and marketingPRICE SENSITIVE01/05/17
UCM Uscom Achieves First Cash Flow Positive Quarter Appendix 4CPRICE SENSITIVE19/04/17
UCM Uscom Achieves First Cash Flow Positive QuarterPRICE SENSITIVE19/04/17
UCM New Uscom Euro Grant for Pulmonary ResearchPRICE SENSITIVE03/04/17
UCM New USCOM Evidence for PreeclampsiaPRICE SENSITIVE30/03/17
UCM China BP Plus and SpiroSonic Regulatory SubmissionsPRICE SENSITIVE22/03/17
UCM Uscom Receives $0.5M R&D Cash RefundPRICE SENSITIVE20/03/17
UCM New BP Plus PatentPRICE SENSITIVE06/03/17
UCM Half Yearly Report and AccountsPRICE SENSITIVE13/02/17
UCM Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
UCM Uscom BPplus Detects New Evidence of Cardiovascular DiseasePRICE SENSITIVE19/01/17
UCM Uscom ends 2016 with record manufacturingPRICE SENSITIVE03/01/17
UCM Uscom Awarded Euro Grant for Lung Cancer DiagnosticPRICE SENSITIVE28/11/16
UCM CE Mark for New Uscom Asthma and COPD Devices-UCM.AX PRICE SENSITIVE31/10/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE28/10/16
UCM Paediatric Sepsis Outcomes Improved With USCOM-UCM.AX PRICE SENSITIVE26/10/16
UCM Uscom Budapest Revenue up 48%-UCM.AX PRICE SENSITIVE10/10/16
UCM Uscom Meets with Chinese Health Minister-UCM.AX PRICE SENSITIVE09/09/16
UCM Preliminary and Annual Report to shareholders-UCM.AX PRICE SENSITIVE17/08/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE21/07/16
UCM Additional Uscom BP Plus US Patent-UCM.AX PRICE SENSITIVE18/07/16
UCM New US Uscom BP Plus Patent-UCM.AX PRICE SENSITIVE11/07/16
UCM Uscom agreement with CIIC Shanghai-UCM.AX PRICE SENSITIVE16/06/16
UCM New Uscom BP Plus Distributor in Vietnam-UCM.AX PRICE SENSITIVE14/06/16
UCM Oversubscribed PP for Strategic Investment-UCM.AX PRICE SENSITIVE08/06/16
UCM Uscom may improve outcomes and reduce cost in surgery-UCM.AX PRICE SENSITIVE03/05/16
UCM Appendix 4C - quarterly-UCM.AX PRICE SENSITIVE12/04/16
UCM Paediatric sepsis mortality reduced 46% with USCOM usePRICE SENSITIVE31/03/16
UCM Uscom BP plus Contracted Into UK NHS Supply ChainPRICE SENSITIVE14/03/16
UCM Half Yearly Report and AccountsPRICE SENSITIVE23/02/16
UCM Appendix 4C - quarterlyPRICE SENSITIVE01/02/16
UCM Uscom BP Plus equal to catheters for Central BP in childrenPRICE SENSITIVE19/01/16
UCM Uscom New SpiroSonic Series of Asthma ProductsPRICE SENSITIVE25/11/15
UCM Uscom US CPT Code and Reimbursement UpdatePRICE SENSITIVE20/11/15
UCM USCOM can replace cardiac catheters in childrenPRICE SENSITIVE09/11/15
UCM Uscom Establishes UK SubsidiaryPRICE SENSITIVE04/11/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE26/10/15
UCM 55% of all China mortality from cardiorespiratory diseasePRICE SENSITIVE17/09/15
UCM Uscom Completes Thor AcquisitionPRICE SENSITIVE01/09/15
UCM Preliminary and Annual Report to shareholdersPRICE SENSITIVE26/08/15
UCM USA FDA clearance for Thor ultrasonic spirometersPRICE SENSITIVE29/07/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/07/15
UCM Reinstatement to Official QuotationPRICE SENSITIVE20/07/15
UCM Uscom - Capital Raise & Acquisition of Thor LaboratoriesPRICE SENSITIVE20/07/15
UCM Suspension from Official QuotationPRICE SENSITIVE17/07/15
UCM Trading HaltPRICE SENSITIVE15/07/15
UCM USCOM signs eight new distribution agreementsPRICE SENSITIVE07/07/15
UCM USCOM Recognised by China National ICU SocietyPRICE SENSITIVE20/05/15
UCM Receiving Research and Development Tax Incentive PaymentPRICE SENSITIVE30/04/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE27/04/15
UCM New Research - USCOM for Hypertension Screening in PregnancyPRICE SENSITIVE21/04/15
UCM AMA Accepts CPT Code for Central Pressure Waveform MeasuresPRICE SENSITIVE31/03/15
UCM Half Yearly Report and AccountsPRICE SENSITIVE24/02/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE29/01/15
UCM USCOM 1A - New Regulatory Registration for ChinaPRICE SENSITIVE27/01/15
UCM Appendix 4C - quarterlyPRICE SENSITIVE21/10/14
UCM New USCOM science in critical applicationsPRICE SENSITIVE04/09/14
UCM TGA Approval for Uscom BP Central Blood PressurePRICE SENSITIVE25/08/14
UCM Preliminary and Annual Report to shareholdersPRICE SENSITIVE18/08/14
UCM Appendix 4C - quarterlyPRICE SENSITIVE28/07/14
UCM Uscom Manufactures First Australian BPplus DevicePRICE SENSITIVE23/06/14
UCM Uscom appoints new US distributor for USCOM 1A monitorPRICE SENSITIVE16/06/14
UCMUscom appoints three new UK distributors for BP monitorPRICE SENSITIVE19/05/14
UCMUscom Announces Successful Capital RaisingPRICE SENSITIVE15/05/14
UCM Uscom Granted Type II Medical Device Sales Cert in China
25/03/19PRICE SENSITIVE
UCM Half Year Accounts
28/02/19PRICE SENSITIVE
UCM Uscom Signs SpiroSonic Deal with US eHealth Leader - Koneksa
07/02/19PRICE SENSITIVE
UCM Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
UCM Uscom Ltd 2018 AGM Presentation
28/11/18PRICE SENSITIVE
UCM Uscom China IP Granted
19/11/18PRICE SENSITIVE
UCM Uscom China Registered
12/11/18PRICE SENSITIVE
UCM Appendix 4C - quarterly
29/10/18PRICE SENSITIVE
UCM Preliminary Final Report
22/08/18PRICE SENSITIVE
UCM Uscom releases new hypertension product
02/08/18PRICE SENSITIVE
UCM Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
UCM New Uscom Measure of Heart Function
21/06/18PRICE SENSITIVE download Created with Sketch. 475.8KB
UCM New US IP for Uscom SpiroSonic Devices
24/05/18PRICE SENSITIVE download Created with Sketch. 480.54KB
UCM Appendix 4C - quarterly
23/04/18PRICE SENSITIVE
UCM BP Plus for US eHealth study
06/03/18PRICE SENSITIVE
UCM Half Yearly Report and Accounts
14/02/18PRICE SENSITIVE
UCM Appendix 4C - quarterly
31/01/18PRICE SENSITIVE
UCM Share placement
19/12/17PRICE SENSITIVE
UCM International Value Investor Takes Strategic Stake in Uscom
18/12/17PRICE SENSITIVE
UCM Uscom Receives $492K R&D Cash Refund
15/12/17PRICE SENSITIVE
UCM Trading Halt
15/12/17PRICE SENSITIVE
UCM New Hypertension Study Recommends Uscom BP Plus Measures
21/11/17PRICE SENSITIVE
UCM Uscom receives GSA listing to sell to US Government
13/11/17PRICE SENSITIVE
UCM Uscom BP plus Central Blood Pressure Monitor Released
30/10/17PRICE SENSITIVE
UCM Appendix 4C - quarterly
27/10/17PRICE SENSITIVE
UCM BP Plus and Mount Everest Hypertension Study
16/10/17PRICE SENSITIVE
UCM USCOM cost effective replacement for ICU Ultrasound
09/10/17PRICE SENSITIVE
UCM Preliminary Final Report
22/08/17PRICE SENSITIVE
UCM Annual Report to shareholders
21/08/17PRICE SENSITIVE
UCM New USCOM 1A digital connectivity feature released
09/08/17PRICE SENSITIVE
UCM Appendix 4C - quarterly
25/07/17PRICE SENSITIVE
UCM Uscom BPplus Distributor for SE Asia
17/07/17PRICE SENSITIVE
UCM TGA for Uscom SpiroSonic Digital Spirometers
13/07/17PRICE SENSITIVE
UCM Euro Funding for Uscom Pulmonary Research
11/07/17PRICE SENSITIVE
UCM Uscom SpiroSonic Devices for Spanish Health Project
01/06/17PRICE SENSITIVE
UCM Uscom SpiroSonic Devices for French Lung Transplant Study
24/05/17PRICE SENSITIVE
UCM Uscom boosts global sales and marketing
01/05/17PRICE SENSITIVE
UCM Uscom Achieves First Cash Flow Positive Quarter Appendix 4C
19/04/17PRICE SENSITIVE
UCM Uscom Achieves First Cash Flow Positive Quarter
19/04/17PRICE SENSITIVE
UCM New Uscom Euro Grant for Pulmonary Research
03/04/17PRICE SENSITIVE
UCM New USCOM Evidence for Preeclampsia
30/03/17PRICE SENSITIVE
UCM China BP Plus and SpiroSonic Regulatory Submissions
22/03/17PRICE SENSITIVE
UCM Uscom Receives $0.5M R&D Cash Refund
20/03/17PRICE SENSITIVE
UCM New BP Plus Patent
06/03/17PRICE SENSITIVE
UCM Half Yearly Report and Accounts
13/02/17PRICE SENSITIVE
UCM Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
UCM Uscom BPplus Detects New Evidence of Cardiovascular Disease
19/01/17PRICE SENSITIVE
UCM Uscom ends 2016 with record manufacturing
03/01/17PRICE SENSITIVE
UCM Uscom Awarded Euro Grant for Lung Cancer Diagnostic
28/11/16PRICE SENSITIVE
UCM CE Mark for New Uscom Asthma and COPD Devices-UCM.AX
31/10/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
28/10/16PRICE SENSITIVE
UCM Paediatric Sepsis Outcomes Improved With USCOM-UCM.AX
26/10/16PRICE SENSITIVE
UCM Uscom Budapest Revenue up 48%-UCM.AX
10/10/16PRICE SENSITIVE
UCM Uscom Meets with Chinese Health Minister-UCM.AX
09/09/16PRICE SENSITIVE
UCM Preliminary and Annual Report to shareholders-UCM.AX
17/08/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
21/07/16PRICE SENSITIVE
UCM Additional Uscom BP Plus US Patent-UCM.AX
18/07/16PRICE SENSITIVE
UCM New US Uscom BP Plus Patent-UCM.AX
11/07/16PRICE SENSITIVE
UCM Uscom agreement with CIIC Shanghai-UCM.AX
16/06/16PRICE SENSITIVE
UCM New Uscom BP Plus Distributor in Vietnam-UCM.AX
14/06/16PRICE SENSITIVE
UCM Oversubscribed PP for Strategic Investment-UCM.AX
08/06/16PRICE SENSITIVE
UCM Uscom may improve outcomes and reduce cost in surgery-UCM.AX
03/05/16PRICE SENSITIVE
UCM Appendix 4C - quarterly-UCM.AX
12/04/16PRICE SENSITIVE
UCM Paediatric sepsis mortality reduced 46% with USCOM use
31/03/16PRICE SENSITIVE
UCM Uscom BP plus Contracted Into UK NHS Supply Chain
14/03/16PRICE SENSITIVE
UCM Half Yearly Report and Accounts
23/02/16PRICE SENSITIVE
UCM Appendix 4C - quarterly
01/02/16PRICE SENSITIVE
UCM Uscom BP Plus equal to catheters for Central BP in children
19/01/16PRICE SENSITIVE
UCM Uscom New SpiroSonic Series of Asthma Products
25/11/15PRICE SENSITIVE
UCM Uscom US CPT Code and Reimbursement Update
20/11/15PRICE SENSITIVE
UCM USCOM can replace cardiac catheters in children
09/11/15PRICE SENSITIVE
UCM Uscom Establishes UK Subsidiary
04/11/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
26/10/15PRICE SENSITIVE
UCM 55% of all China mortality from cardiorespiratory disease
17/09/15PRICE SENSITIVE
UCM Uscom Completes Thor Acquisition
01/09/15PRICE SENSITIVE
UCM Preliminary and Annual Report to shareholders
26/08/15PRICE SENSITIVE
UCM USA FDA clearance for Thor ultrasonic spirometers
29/07/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
27/07/15PRICE SENSITIVE
UCM Reinstatement to Official Quotation
20/07/15PRICE SENSITIVE
UCM Uscom - Capital Raise & Acquisition of Thor Laboratories
20/07/15PRICE SENSITIVE
UCM Suspension from Official Quotation
17/07/15PRICE SENSITIVE
UCM Trading Halt
15/07/15PRICE SENSITIVE
UCM USCOM signs eight new distribution agreements
07/07/15PRICE SENSITIVE
UCM USCOM Recognised by China National ICU Society
20/05/15PRICE SENSITIVE
UCM Receiving Research and Development Tax Incentive Payment
30/04/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
27/04/15PRICE SENSITIVE
UCM New Research - USCOM for Hypertension Screening in Pregnancy
21/04/15PRICE SENSITIVE
UCM AMA Accepts CPT Code for Central Pressure Waveform Measures
31/03/15PRICE SENSITIVE
UCM Half Yearly Report and Accounts
24/02/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
29/01/15PRICE SENSITIVE
UCM USCOM 1A - New Regulatory Registration for China
27/01/15PRICE SENSITIVE
UCM Appendix 4C - quarterly
21/10/14PRICE SENSITIVE
UCM New USCOM science in critical applications
04/09/14PRICE SENSITIVE
UCM TGA Approval for Uscom BP Central Blood Pressure
25/08/14PRICE SENSITIVE
UCM Preliminary and Annual Report to shareholders
18/08/14PRICE SENSITIVE
UCM Appendix 4C - quarterly
28/07/14PRICE SENSITIVE
UCM Uscom Manufactures First Australian BPplus Device
23/06/14PRICE SENSITIVE
UCM Uscom appoints new US distributor for USCOM 1A monitor
16/06/14PRICE SENSITIVE
UCMUscom appoints three new UK distributors for BP monitor
19/05/14PRICE SENSITIVE
UCMUscom Announces Successful Capital Raising
15/05/14PRICE SENSITIVE
(20min delay)
Last
3.2¢
Change
0.000(0.00%)
Mkt cap ! $3.506M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 150000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
3.2¢ 200000 1
View Market Depth
Last trade - 16.12pm 29/11/2024 (20 minute delay) ?
UCM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.